Free cookie consent management tool by TermsFeed
Home > AM24 > Abstract Submission

Abstract Submission

Abstract submissions closed February 13, 2024, 11:59 p.m. U.S. Eastern Time.

The ISTSS 40th Annual Meeting will focus on innovative strategies to apply basic science ‎knowledge to the assessment and treatment of traumatic stress, as well as on the translation of ‎scientific findings into actionable interventions for the global community. In pursuit of this goal, we ‎seek submissions specific to the field of traumatic stress on topics related—but not limited—to:‎

  1. Application of biomedical science findings to inform assessments and interventions for ‎traumatic stress symptoms/disorders. ‎
  2. Research investigating the psychological, biological, social and behavioral ‎mechanisms that underlie post-trauma mental health.‎
  3. Research taking a life course perspective to address to address ‎the spectrum of ‎translational science research.‎
  4. Evidence-based practices and innovative research in basic science, intervention ‎development and implementation, and policy. ‎
  5. Innovative transdiagnostic treatment approaches addressing the myriad ‎consequences of trauma.‎
  6. Cutting-edge research methodologies and statistical frameworks for translational ‎science research.‎
  7. Ethical implications and considerations associated with the application of translational ‎science in traumatic stress studies.‎
  8. Ways to effectively communicate and disseminate research to different stakeholders.‎
  9. Ways to cultivate translational science and interdisciplinary exchange. ‎
  10. Challenges and debates in the area of translational science.‎
  11. Translational science as applicable to the global community.‎

Participation Limit (Two Submissions Per Person)

To promote participation by a wide range of presenters, individuals are limited to two abstracts being submitted ‎that indicate they have a presenting role.

Who Should Submit the Abstract?

We strongly recommended that the individual who will be presenting in-person ‎be the one to submit your poster abstract. If someone else submits the abstract on behalf of the primary presenter, that ‎person will become the point-person and receive all follow-up emails that will need to be forwarded to the primary ‎presenter.

Learn More About Presenter Roles

Other Policies to Note

  • Presentations should be original contributions and that any presentation concerning work that has been ‎presented elsewhere should provide new information or a new perspective relative to the previous ‎presentation(s).
  • Publication of the work, such as in a journal, prior to the date of abstract submission (not the abstract ‎submission deadline) is prohibited. ‎ ‎
  • Proposal descriptions must be sufficiently detailed to allow the relevance, originality and ‎feasibility to be ‎judged. For research presentation abstracts, submissions of findings are ‎strongly encouraged.‎
  • Incomplete proposals (draft status) will not be considered.
  • All live presentations may be recorded for asynchronous viewing.


Competition for oral presentations is high; therefore, we recommend taking the time to enter the best submission possible. Keep in ‎mind that many high quality proposals must be turned away simply due to lack of space. See examples of model ‎and problematic oral presentation proposals here. 

‎‎Review Process

‎Submissions are rated for rigor (scientific, clinical or intellectual), relevance for ISTSS members and consistency ‎with the meeting theme. Proposal descriptions must be sufficiently detailed to allow evaluation of these criteria. ‎‎

‎‎CME Requirements

See an explanation of speaker requirements related to commercial ‎relationships.

‎‎COVID Protocol

‎ISTSS will require attendees at the 2024 annual meeting to follow all COVID-19 guidelines that are in place at the ‎time of the meeting from the U.S. Centers for Disease Control and Prevention, state and local government, and ‎conference hotel, The Westin Bonaventure Hotel & Suites, Los Angeles. ‎Individuals should contact the Executive Director to address specific circumstances or exceptional situations.‎


Email: [email protected] 
Phone: +1-847-686-2234